Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jesus E. Sanchez-Garavito"'
Autor:
Yan Luo, Martha E. Gadd, Yaqing Qie, Andrea Otamendi-Lopez, Jesus E. Sanchez-Garavito, Mieu M. Brooks, Maria J. Ulloa Navas, Tanya Hundal, Shuhua Li, Vanessa K. Jones, Yanyan Lou, Tushar Patel, Roxana Dronca, Mohamed A. Kharfan-Dabaja, Haidong Dong, Alfredo Quinones-Hinojosa, Hong Qin
Publikováno v:
Molecular Therapy: Oncology, Vol 32, Iss 4, Pp 200891- (2024)
Chimeric antigen receptor (CAR) T cell therapy has encountered limited success in solid tumors. The lack of dependable antigens and the immunosuppressive tumor microenvironment (TME) are major challenges. Within the TME, tumor cells along with immuno
Externí odkaz:
https://doaj.org/article/eba59695e4f1498cac886149059c76a1
Autor:
Fidel Lopez-Verdugo, Jorge Sanchez-Garcia, Shanni Baraki, Zachary J. Kastenberg, Jesus E. Sanchez-Garavito, Ivan Zendejas, Diane Alonso, M. Kyle Jensen, Shiro Fujita, Rebecka L. Meyers, Linda Book, Manuel I. Rodriguez-Davalos
Publikováno v:
Journal of Surgical Research. 290:28-35
Autor:
Andres Ramos-Fresnedo, Erik H. Middlebrooks, Oluwaseun O. Akinduro, Mark E. Jentoft, Sujay A. Vora, Alyx B. Porter, Jesus E. Sanchez-Garavito, Alfredo Quinones-Hinojosa, Carlos Perez-Vega, Bernard R. Bendok, Kaisorn L. Chaichana, Daniel M. Trifiletti, Ricardo A. Domingo, Wendy Sherman, Michael J. Link, Paul D. Brown
Publikováno v:
Journal of neurosurgery.
OBJECTIVE Multiple meningiomas (MMs) occur in as many as 18% of patients with meningioma, and data on progression-free survival (PFS) are scarce. The objective of this study was to explore the influence of the number of lesions and clinical character
Autor:
Andres Ramos-Fresnedo, Mark E. Jentoft, Michael J. Link, Ricardo A. Domingo, Erik H. Middlebrooks, Jesus E. Sanchez-Garavito, Paul D. Brown, Kaisorn L. Chaichana, Oluwaseun O. Akinduro, Bernard R. Bendok, Alfredo Quinones-Hinojosa, Daniel M. Trifiletti, Carlos Perez-Vega, Alyx B. Porter, Wendy Sherman
Publikováno v:
Neuro-Oncology. 23:vi158-vi158
INTRODUCTION Multiple meningiomas (MM) occurs in up to 18% of meningioma patients and progression data are scarce. The objective of this study is to explore the influence of number of lesions and clinical characteristics on progression-free survival